Ovarian cancer therapy using CD40 ligand (CD40L)
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA180323
- Recipient
-
Multimeric Biotherapeutics, Inc. UEI MJFMX1Q4KGE7
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $223,157
Award facts
- Assistance listing
- 93.393 Cancer Cause and Prevention Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- San Diego, CA 92109, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$742 | |
| Original award | $223,899 |
Quick answers
Who received award R43CA180323?
R43CA180323 was awarded to Multimeric Biotherapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on June 1, 2014.
How much is award R43CA180323 worth?
$223,157 has been obligated on R43CA180323.
Which agency awarded R43CA180323?
National Institutes of Health (Department of Health and Human Services) awarded R43CA180323, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award